CLINICAL_TRIALS
trial_result
· 2012-04-19
Clinical Trial Update: Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy [Phase 4]
Summary
Open-label Phase 4 trial comparing etanercept to conventional DMARD therapy in rheumatoid arthritis. Results were posted on 2012-04-19.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2012-04-19